2012
DOI: 10.1590/s0066-782x2012005000095
|View full text |Cite
|
Sign up to set email alerts
|

Repolarização ventricular em pacientes diabéticos: caracterização e implicações clínicas

Abstract: We concluded that diabetes causes prolongation and spatial dispersion of repolarization, and it may contribute to a greater ventricular electrical instability, whose expected clinical expression may be malignant ventricular arrhythmias.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(11 citation statements)
references
References 34 publications
(26 reference statements)
0
9
1
Order By: Relevance
“…They have been associated with the risk of arrhythmogenesis. They have also been shown to be prolonged in diabetic patients ( 17 , 18 ). The prevalence of prolonged QTc has been reported to be as high as 16% in type 1 diabetes ( 19 ) and 30.1% in T2DM ( 20 ).…”
Section: Discussionmentioning
confidence: 98%
“…They have been associated with the risk of arrhythmogenesis. They have also been shown to be prolonged in diabetic patients ( 17 , 18 ). The prevalence of prolonged QTc has been reported to be as high as 16% in type 1 diabetes ( 19 ) and 30.1% in T2DM ( 20 ).…”
Section: Discussionmentioning
confidence: 98%
“…The studies reached different conclusions regarding the association between QT parameters prolongation and cardiac end points. Previous study has evaluated the Tp-e interval and other QT parameters in patients with diabetes [ 36 ]. However, there has been a debate on dynamic changes in Tp-e interval like as QT interval so we measured also Tp-e/QT ratio and Tp-e/QTc ratio that is known to be relatively constant parameters and incorporation of these indices may have improved the accuracy of our study.…”
Section: Discussionmentioning
confidence: 99%
“…Given the evidence presented here, it is clear that increased ROS can lead to intracellular organelle dysfunction and arrhythmias in cardio-metabolic disorders such as diabetes mellitus and hypertension. It is therefore prudent that the at-risk population is identified, which would enable early intervention to reduce arrhythmic mortality (Cardoso et al, 2003 ; Salles et al, 2005 ; Stettler et al, 2007 ; Clemente et al, 2012 ; Tse, 2016a , c ; Tse and Yan, 2016a , b ).…”
Section: Clinical Relevance and Future Perspectivesmentioning
confidence: 99%